image: Hesperos's reconfigurable human-based body-on-a-chip system mimics the way human organs interact with each other and respond to drug testing. This material relates to a paper that appeared in the June 19, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by C.W. McAleer at Hesperos Inc. in Orlando, FL; and colleagues was titled, 'Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics.' view more
Credit: Hesperos